[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

IN2014DN10385A - - Google Patents

Download PDF

Info

Publication number
IN2014DN10385A
IN2014DN10385A IN10385DEN2014A IN2014DN10385A IN 2014DN10385 A IN2014DN10385 A IN 2014DN10385A IN 10385DEN2014 A IN10385DEN2014 A IN 10385DEN2014A IN 2014DN10385 A IN2014DN10385 A IN 2014DN10385A
Authority
IN
India
Prior art keywords
agent
effervescent
acid
dosage form
chewable dosage
Prior art date
Application number
Inventor
MarkEdward STELLA
John Richard Entwisle
Jason William Newlon
Christine Louie Naykki
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of IN2014DN10385A publication Critical patent/IN2014DN10385A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/695—Silicon compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7016—Disaccharides, e.g. lactose, lactulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/80—Polymers containing hetero atoms not provided for in groups A61K31/755 - A61K31/795
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/10—Carbonates; Bicarbonates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A61K9/2036—Silicones; Polysiloxanes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Physiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nutrition Science (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)

Abstract

An effervescent chewable dosage form that comprises a pH neutralization agent an acid and an effervescent agent. The chewable dosage form can also further comprise simethicone a sweetener and a lubricant. The pH neutralization agent can be calcium carbonate the acid can be citric acid and the effervescent agent can be sodium bicarbonate.
IN10385DEN2014 2012-06-12 2013-06-12 IN2014DN10385A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261658430P 2012-06-12 2012-06-12
PCT/US2013/045303 WO2013188483A1 (en) 2012-06-12 2013-06-12 Effervescent dosage form

Publications (1)

Publication Number Publication Date
IN2014DN10385A true IN2014DN10385A (en) 2015-08-14

Family

ID=48672843

Family Applications (1)

Application Number Title Priority Date Filing Date
IN10385DEN2014 IN2014DN10385A (en) 2012-06-12 2013-06-12

Country Status (12)

Country Link
US (1) US10617714B2 (en)
EP (1) EP2734192B1 (en)
CN (1) CN104363897A (en)
AU (1) AU2013274378B2 (en)
BR (1) BR112014030680B1 (en)
CA (1) CA2876062C (en)
ES (1) ES2541723T3 (en)
IN (1) IN2014DN10385A (en)
MX (1) MX368363B (en)
PL (1) PL2734192T3 (en)
RU (1) RU2014149581A (en)
WO (1) WO2013188483A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2604124A1 (en) * 2011-12-16 2013-06-19 Nestec S.A. Soluble non-dairy creamer tablet surface-treated with carbohydrate
US20180168995A1 (en) * 2015-06-29 2018-06-21 Elc Man Llc Particles With Cross-Linked Coatings For Cosmetic Applications
CN107114795A (en) * 2017-07-06 2017-09-01 胥永贵 A kind of weak base is replenished the calcium, soda alkalization ginger preparation and its preparation method and application
US11793876B2 (en) 2019-10-18 2023-10-24 L. Perrigo Company Bulk polyethylene glycol compositions
WO2022060310A1 (en) * 2020-09-18 2022-03-24 Pharmacti̇ve İlaç Sanayi̇ Ve Ti̇caret A.Ş. Pharmaceutical compositions comprising calcium carbonate, magnesium carbonat and simethicone
CN117651496A (en) * 2021-06-17 2024-03-05 优鲜沛蔓越莓公司 Rare sugars in food and beverage products
US12053484B2 (en) 2021-10-29 2024-08-06 Medicated Chews, Llc Simethicone chewable composition

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1518364A (en) 1976-05-05 1978-07-19 Beecham Group Ltd Pharmaceutical composition
US4198390A (en) 1979-01-31 1980-04-15 Rider Joseph A Simethicone antacid tablet
US4396604A (en) 1982-05-17 1983-08-02 Norcliff Thayer, Inc. Simethicone antacid lozenge
US4678661A (en) * 1983-09-28 1987-07-07 Gerhard Gergely Effervescent composition and method of making same
JPS6092378A (en) 1983-09-28 1985-05-23 ゲルハルト・ゲルゲリー Foamable mixture, particularly for foaming tablet, foaming tablet manufactured thereby and manufacture
US4650669A (en) 1985-07-30 1987-03-17 Miles Laboratories, Inc. Method to make effervescent calcium tablets and calcium tablets produced thereby
GB8909793D0 (en) 1989-04-28 1989-06-14 Beecham Group Plc Pharmaceutical formulation
US5073384A (en) 1989-10-19 1991-12-17 Valentine Enterprises, Inc. Maltodextrin/defoaming composition combinate
ES2079743T3 (en) 1991-07-01 1996-01-16 Gergely Gerhard TABLET FOR SUCKING OR CHEWING.
WO1994000107A1 (en) 1992-06-30 1994-01-06 The Procter & Gamble Company Effervescent calcium supplements
US5330760A (en) * 1992-08-27 1994-07-19 Sterling Winthrop Inc. Effervescent antacid
FR2705966B1 (en) 1993-06-04 1995-08-25 Dow Corning Sa Antifoam compositions useful in particular for the treatment of gastric disorders.
JPH11509854A (en) 1995-07-31 1999-08-31 ゲルゲリイ、ゲルハルト Effervescent chewable tablet
KR970706802A (en) 1995-09-07 1997-12-01 가와구치 시게키 LOW-PRESSURE TABLETED EFFER VESCENT PREPARATION
US5807577A (en) 1995-11-22 1998-09-15 Lab Pharmaceutical Research International Inc. Fast-melt tablet and method of making same
US6489346B1 (en) 1996-01-04 2002-12-03 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
US5888544A (en) 1996-06-20 1999-03-30 Gerhard Gergely Effervescent system for effervescent tablets and effervescent granules
DE19814256A1 (en) 1998-03-31 1999-10-07 Asta Medica Ag Solid, fast-breaking cetirizine formulations
GB9825033D0 (en) 1998-11-13 1999-01-13 Nycomed Pharma As Process
US6296868B1 (en) 1998-11-19 2001-10-02 Advanced Technology Pharmaceuticals Corporation Chewable tablets containing mannitol and aspartame
DE19859231A1 (en) 1998-12-21 2000-06-29 Kurt Heinz Bauer Foaming antacid suspension tablets
US6589555B2 (en) 1999-12-29 2003-07-08 Mahendra Pandya Effervescent vitaceutical compositions and related methods
US6544557B2 (en) 2001-01-09 2003-04-08 Pan Pharmaceutical Limited Effervescent tablet compositions
US20030235613A1 (en) 2002-06-19 2003-12-25 Cts Chemical Industries Ltd. Popping oral administration form
US20040223921A1 (en) 2003-05-07 2004-11-11 Rau Allen H. Oral care tablet
US20050074489A1 (en) 2003-10-01 2005-04-07 Pediamed Pharmaceuticals, Inc. Effervescent and effervescent-dispersion compositions for medicaments and methods of use thereof
ITMI20040242U1 (en) 2004-05-24 2004-08-24 Istituto Pirri S R L CONTAINER FOR EFFERVESCENT TABLETS
WO2006044595A2 (en) 2004-10-13 2006-04-27 Cadbury Adams Usa Llc Effervescent pressed gum tablet compositions
US20090004248A1 (en) * 2007-06-29 2009-01-01 Frank Bunick Dual portion dosage lozenge form
EP2189154A1 (en) 2008-11-25 2010-05-26 Gnosis S.p.A. Effervescent tablets and mouth-soluble granulates of S-adenosyl methionine and process for the preparation thereof
CN101966165B (en) 2009-07-14 2012-06-13 无锡健而乐医药科技有限公司 Solid effervescent mixture for the oral absorption
WO2011113965A1 (en) 2010-03-18 2011-09-22 Farmalider, S.A. Pharmaceutical composition in solid form containing isoflavones, a calcium salt and vitamin d3
CN102232967A (en) * 2010-04-21 2011-11-09 武汉同济现代医药有限公司 Novel oral effervescent agent for calcium supply and preparation method thereof
US20140371174A1 (en) 2013-06-12 2014-12-18 The Procter & Gamble Company Effervescent Dosage Form

Also Published As

Publication number Publication date
BR112014030680B1 (en) 2022-08-30
US20190262392A1 (en) 2019-08-29
PL2734192T3 (en) 2015-09-30
BR112014030680A2 (en) 2017-06-27
CN104363897A (en) 2015-02-18
AU2013274378A1 (en) 2015-01-15
WO2013188483A1 (en) 2013-12-19
EP2734192A1 (en) 2014-05-28
EP2734192B1 (en) 2015-04-15
AU2013274378B2 (en) 2016-06-02
US10617714B2 (en) 2020-04-14
MX368363B (en) 2019-09-30
CA2876062A1 (en) 2013-12-19
RU2014149581A (en) 2016-07-10
ES2541723T3 (en) 2015-07-24
CA2876062C (en) 2017-09-12
MX2014015253A (en) 2015-03-05

Similar Documents

Publication Publication Date Title
IN2014DN10385A (en)
PH12015501070B1 (en) Surfactant systems for zinc containing compositions
UA115811C2 (en) Stable oral solutions for combined api
GB201215159D0 (en) Composition
EA201600442A1 (en) SOFT PHARMACEUTICAL COMPOSITION ON WATER BASIS CONTAINING TAPENTADOL
PH12014502856A1 (en) Solid pharmaceutical preparation containing levothyroxine
MX2015012109A (en) Dual use oral pharmaceutical composition tablets of sulfate salts and methods of use thereof.
AR100452A1 (en) DENTAL COMPOSITIONS THAT HAVE OPTIMIZED PRESERVANTS
MX2015006913A (en) Oral care compositions comprising calcium carbonate and a preservative system based on benzyl alcohol or benzoic acid, and an alkylene glycol.
EP2892348A4 (en) Disinfectant formulation comprising calcium hydroxide and sodium hypochlorite
MX2017009659A (en) Compositions containing arsenic and their use in methods of treatment.
TR200909786A1 (en) Effervescent tablet and granule formulation containing cefixime.
FR2967054B1 (en) CONSERVATIVE SYSTEM
MX365972B (en) Oral care compositions.
IN2014MN01382A (en)
PH12017501603A1 (en) Solid oral care composition
PE20151432A1 (en) SUSTAINED RELEASE LORAZEPAM FORMULATIONS
TR201005241A1 (en) Pregabalin solution formulation for controlled release.
TR201009399A2 (en) Rapidly soluble effervescent rosuvastatin formulations.
FR2958156B1 (en) COSMETIC COMPOSITION COMPRISING A COSMETIC ACTIVE AND AN EFFERVESCENT SYSTEM
MX2008015058A (en) Prednisolone salt formulations.
AR086153A1 (en) ADDITIVE FOR FINAL PRE-RINSE OF BOTTLE WASHING MACHINES
RO130486A8 (en) Pharmaceutical formula for chewable minted tablets with calcium and vitamin d3 content
UA81930U (en) Insectoacaricide "preparation 30b (m)"
PH22015000589U1 (en) Effervescent multivitamin tablet